Global Enteral Syringe Market- Market Overview:

The Global enteral syringe market is expected to grow from USD 704.1 million in 2022 to USD 1,001.3 million by 2030, at a CAGR of 4.5% during the Projection period 2023-2030. The rise in government initatives mainly drives the growth of the enteral syringe market.

In hospitals, clinics, and private residences, enteral syringes are frequently used to provide medications and nutritional therapy via the oral, rectal, or sublingual route of administration. They come in sizes ranging from 1 ml to 60 ml. Purple plungers are a distinguishing feature of enteral syringes from IV syringes and signal that the medication in the syringe should be administered via the enteral route. Additionally, enteral syringes are used to measure medication precisely when it is impossible to do so using a spoon or cup and it is administered to patients. Additionally, they are used to provide feeding to patients confined to intensive care units and to provide medications to newborns and young children (ICU). They are created or constructed in accordance with the most recent international standard, ISO-80369-3. The incidence of chronic diseases is predicted to rise along with the number of neonatal NICU admissions and the worldwide geriatric population, which will all contribute to the expansion of the enteral syringe market. For instance, according to the World Health Organization's (WHO) 2012 report, more than 1.1 million preterm babies die each year, while 75 percent may survive with access to affordable treatment. In addition, over 15 million premature babies are born each year. That is greater than one in ten infants.

Sample Request: - Global Enteral Syringe Market

Market Dynamics:

Drivers:                          

• Rising Prevalence of Critical Care Products

One of the primary factors propelling the expansion of the worldwide enteral syringe market is the rising prevalence of critical care conditions. Globally, there is a rising need for enteral feeding products due to the prevalence of critical care disorders such as head and neck cancer, preterm births, newborns, motor neuron disease, multiple sclerosis, stroke, head injuries, and psychiatric illness. This will probably encourage the use of enteral syringes in turn. The prevalence of head and neck cancer is rising on a global scale. Smoking and frequent alcohol use are the main risks linked to the progression of oral cancer. The tongue, oral mucosa, mouth, and oropharynx can all develop oral cancer (the area of the throat at the back of the mouth).

Restraints:                                             

• Enteral Feeding

Enteral feeding carries the possibility of tubing misconnection, which can result in major issues and, in extreme circumstances, even patient death. For neonatal and pediatric patients, ENFit designs were created to reduce the danger of tubing misconnections under the new ISO 80369-3 standards. However, ENfit devices are currently facing further difficulties. The ENfit design also creates problems for workflow. The additional tasks of routinely cleaning feeding tubes and syringe moats, as well as the use of several connectors and adapters for enteral drug delivery, fall on the shoulders of carers or nursing personnel.

Opportunities:

• Rise in Partnerships

To boost their market share and presence globally, vendors in the sector are working and forming partnerships with other businesses. In order to increase their global footprint, they are also concentrating on integrating the distributor network into the supply chain. For instance, in July 2020, Smiths Medical announced its strategic public-private partnership with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense of the Department of Defense and the Biomedical Advanced Research and Development Authority (BARDA), a division of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response (JPEO-CBRND). To support the Operation Warp Speed immunization campaign, this cooperation with BARDA and JPEO-CBRND involves a $20 million investment for enhanced syringe and needle device production.

Challenges:

• Few Difficulties

Pharmacy professionals and medication safety specialists advise hospitals to exercise caution before implementing the ENFit design. Hospitals have informed regulatory bodies about the escalating safety concerns with the usage of ENfit devices as a result of the increased danger and misconnection associated with their use in NICUs. The market for enteral feeding syringes is anticipated to grow slowly due to a variety of challenges and inadequate reimbursements, but it may face difficulties due to a shortage of qualified specialists.

Segmentation Analysis:

The global enteral syringe market has been segmented based on product type, application, patient group, and region.

By Product Type

The product type segment is catheter tip syringes, single use enteral syringes, home use enteral syringes, and others. The single use enteral syringes segment led the largest share of the enteral syringe market with a market share of around 40.5% in 2022. Enteral feeds, liquid drugs, or nutrients can now be securely administered to patients of all ages using new single-use ENFit ISO standard enteral syringes. In order to set them apart from other IV feeding systems, enteral syringes (single-use/reusable) now have ENFit compatibility and are painted a uniform shade of purple. A female ENFit connection is also included with low-dose syringes. Additionally, leading manufacturers are now getting FDA approval and complying with ENFit standard design (new ISO80369 standard). For a seamless transition, the safety systems are also compatible with all other enteral feeding devices used in clinic, hospital, and home care settings.

By Application

The application segment is neurological disease, oncology, GI related disease, malnutrition, and others. The oncology segment led the largest share of the enteral syringe market  with a market share of around 42.3% in 2022. The market will grow as a result of the rising incidence of cancer and chronic diseases, as well as the rise in hospital admissions for various lifestyle diseases among adult and newborn populations. According to data from the World Health Organization's International Agency for Research on Cancer (WHO), there were more than 18 million new cancer diagnoses worldwide in 2018. Additionally, a rise in NICU admissions on a worldwide scale will spur expansion internationally.

By Patient Group

The patient group segment is adults and neonatal & pediatrics. The neonatal & pediatrics segment led the largest share of the enteral syringe market with a market share of around 58.3% in 2022. The prevalence of lifestyle diseases and other conditions including diabetes, as well as the growing elderly population, are also projected to contribute to the market's expansion. Another important aspect that is anticipated to fuel the expansion of the enteral syringe market is the rise in newborn hospitalizations and the prevalence of cancer.

Global Enteral Syringe Market   - Sales Analysis.

The sale of the enteral syringe market expanded at a CAGR of 3.2% from 2016 to 2022.

Enteral syringes are primarily employed for the oral, rectal, or sublingual administration of medications and nutritional therapy. They come in sizes ranging from 1 ml to 60 ml and are frequently used in households, hospitals, and clinics. Newly released enteral syringes are made in accordance with the most recent ISO-80369-3 international standard. Through the enteral route, medications can be administered directly into the gastrointestinal tract. The most frequent use of enteral syringes is to administer oral liquid medication and nourishment. These syringes function and are intended for use similarly to enteral feedings. Purple plungers on enteral syringes serve as a visual cue that the medication within must be injected intravenously. These syringes are distinguished from IV syringes by the use of the colour purple.

These syringes are used for a variety of tasks, including accurate liquid medication dosing for patients when a medicine cup or spoon cannot be used to measure the dosage, dosing liquid medications for prohibited substances, and delivering medicine to infants and young children. These syringes come in a variety of varieties, including single-use and home-use syringes. The demand for enteral syringes is anticipated to rise along with the number of admissions to intensive care units for neonates and critical care patients. This is because patients in critical care and newborns in neonatal intensive care are unable to swallow medication or consume food (due to early birth or other difficulties).

Thus, owing to the aforementioned factors, the global enteral syringe market  is expected to grow at a CAGR of 4.5% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the enteral syringe market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the enteral syringe market and held a 38.2% share of the market revenue in 2022.

• The North America region witnessed a major share. Due to the sharp increase in the number of baby boomers with chronic illnesses and the rise in the number of premature births in developing nations like US. One significant aspect that is anticipated to accelerate the growth and demand of the enteral syringe market is the increase in premature births that lead to neonatal hospitalizations. Additionally, the rise in chronic conditions including cancer, malnutrition, and gastrointestinal illnesses is anticipated to have a positive impact on the global market throughout the course of the Projection period.
• Asia-Pacific is anticipated to experience significant growth during the Projection period. Due to the surge in newborn hospitalizations and increased cancer prevalence. Over the Projection period, Asia-Pacific is anticipated to increase rapidly. The global enteral syringe market is anticipated to expand as a result of rising misconnection rates, rising ENFit design-based enteral syringe use, and the need for improved safety while using enteral syringes.

Global Enteral Syringe Market   - Country Analysis:

• Germany

Germany's enteral syringe market size was valued at USD 0.75 million in 2022 and is expected to reach USD 1.19 million by 2030, at a CAGR of 6% from 2023 to 2030. Due to the rise in hospital admissions for this category of disease in the Germany and the rising prevalence of chronic diseases including cancer and neurological disorders.

• China

China’s enteral syringe market size was valued at USD 0.78 million in 2022 and is expected to reach USD 1.26 million by 2030, at a CAGR of 6.2% from 2023 to 2030. Due to an increase in the number of premature births and fragile neonates that require enteral nutrition. Additionally, it is projected that growing consumer knowledge of enteral nutrition and improved healthcare infrastructure in this region's emerging economies will promote market expansion.

• India

India's enteral syringe market size was valued at USD 0.60 million in 2022 and is expected to reach USD 0.96 million by 2030, at a CAGR of 6.1% from 2023 to 2030. Due to the sharp increase in the number of baby boomers with chronic illnesses and the rise in the number of premature births in developing nations like India.

Key Industry Players Analysis:

To increase their market position in the global enteral syringe market  business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.       

• Abbott Laboratories Inc.
• Gerresheimer AG
• Terumo Corp.
• Becton
• Dickinson and Company
• Merit Medical Systems Inc.
• Medline Industries Inc.
• Cardinal Health Inc.
• Schott AG
• Braun Melsungen AG
• Retractable Technologies Inc.
• Smith’s Medical
• Terumo Medical Corporation

Latest Development:

• In April 2022, Takeda announced that TAKHZYRO (lanadelumab-flyo) injection single-dose prefilled syringe will be offered in the United States to treat patients 12 years of age and older for the treatment of hereditary angioedema (HAE).
• In January 2022, A division of Owen Mumford Ltd. called Owen Mumford Pharmaceutical Services was granted approval to market the UniSafe 1mL safety device for pre-filled syringes as a combination product in Asia.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	4.5%
Market Size	704.1 million in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Product Type, By Application, By Patient Group, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Abbott Laboratories Inc., Gerresheimer AG, Terumo Corp., Becton, Dickinson and Company, Merit Medical Systems Inc., Medline Industries Inc., Cardinal Health Inc., Schott AG, Braun Melsungen AG, Retractable Technologies Inc., Smith’s Medical, and Terumo Medical Corporation.
By Product Type	Catheter Tip Syringes Single Use Enteral Syringes Home Use Enteral Syringes Others
By Application	Neurological Disease Oncology GI Related Disease Malnutrition Others
By Patient Group	Adults Neonatal & Pediatrics
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Enteral Syringe Market By Product Type:

• Catheter Tip Syringes
• Single Use Enteral Syringes
• Home Use Enteral Syringes
• Others

Global Enteral Syringe Market By Application:

• Neurological Disease
• Oncology
• GI Related Disease
• Malnutrition
• Others

Global Enteral Syringe Market By Patient Group:

• Adults
• Neonatal & Pediatrics

Global Enteral Syringe Market By Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- If the enteral syringe market is permitted to operate in high-tax areas, their business will suffer. Exports are hampered by high taxes, which also affect international trade. A market for enteral syringe can thrive in low-tax jurisdictions and generate sizable earnings that can be allocated to R&D initiatives. The organisation may also look into the tax rules that apply to the firm in order to understand the goals and objectives of the host government in new industries. Due to the harm done to exports and relationships with other trading partners throughout the world, high trade barriers may exacerbate the current economic crisis.

Economic Factors- A country's economic development has a direct impact on an organization's performance. There are several opportunities for growing the market for enteral syringe s because of developing economies. In a similar vein, it's important to understand where the industrial lifecycle is at. Entry into mature sectors may be more difficult than entry into enterprises in the growth stage due to market saturation. The amount of money spent by the government of the host country on developing essential infrastructure has an effect on how lucrative the market for enteral syringe s is as well. A strong infrastructure makes it easier for businesses to operate, which raises the prospect of the nation's gold sector flourishing.

Social factors- The power distance in a culture indicates the acceptance of hierarchy and income inequality. enteral syringe business management strategies must change as they enter markets with high or low power distances. Rising inequality in many countries is changing the power structure, which has a big impact on the global enteral syringe market. To modify its marketing and advertising methods, the market for enteral syringes must do research on the prevalent gender stereotypes. Civilizations with fewer gender stereotypes would employ different marketing and human resource strategies than conventional, patriarchal societies with well defined gender roles.

Technological Factors- Current technical advancements must be carefully analyzed if the market for enteral syringes is to stay ahead of the competition. It's important to consider how 5G enhances user experience, speed, and access to boost productivity. These technical developments have the potential to radically change an economic sector and the rules that determine market actors' success. The technology's level of growth and maturity within the pertinent industry must also be taken into account. By focusing on new technology developments and entering markets where technological change has not yet reached its full potential, the enteral syringe s industry can increase its market share.

Environmental Factors- Due to the rising environmental degradation and technical advancement, businesses are now compelled to utilize cutting-edge recycling and waste management solutions. In many countries, recycling is almost regarded as a commercial imperative. The market for enteral syringes must also implement efficient waste management practices in organizational divisions located in or near urban areas. Many countries have put in place strict measures to protect their urban areas by effectively managing their rubbish. Some countries offer financial assistance to promote the use of renewable energy sources. The enteral syringe s market can benefit from it and invest in renewable technology to ensure long-term viability. This investment will boost brand recognition, which will increase stakeholder satisfaction and expand the customer base.

Legal Factors- The market for enteral syringes must adhere to the rules governing employee/labor health and safety since some countries have rigorous regulations to ensure worker safety. pregnancy cushion Giving its workers a safe place to work is essential morally and ethically. When developing human resource practices, such as the ones mentioned above, anti-discrimination laws (such as equal employment opportunity laws) must also be carefully taken into account because discriminatory lawsuits against employers harm an organization's reputation and impair its ability to attract and retain talent. Data protection has become a critical problem as a result of consumer worries about their security and privacy. The market for enteral syringes must consider data protection rules in order to protect customer data.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Product Type
     • 3.2. Market Attractiveness Analysis By Application
     • 3.3. Market Attractiveness Analysis By Patient Group
     • 3.4. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Rising Prevalence of Critical Care Products
   • 3. Restraints
     • 3.1. Enteral Feeding
   • 4. Opportunities
     • 4.1. Rise in Partnerships
   • 5. Challenges
     • 5.1. Few Difficulties

6. Global Enteral Syringe Market Analysis and Projection, By Product Type
   • 1. Segment Overview
   • 2. Catheter Tip Syringes
   • 3. Single Use Enteral Syringes
   • 4. Home Use Enteral Syringes
   • 5. Others
7. Global Enteral Syringe Market Analysis and Projection, By Application
   • 1. Segment Overview
   • 2. Neurological Disease
   • 3. Oncology
   • 4. GI Related Disease
   • 5. Malnutrition
   • 6. Others
8. Global Enteral Syringe Market Analysis and Projection, By Patient Group
   • 1. Segment Overview
   • 2. Adults
   • 3. Neonatal & Pediatrics
9. Global Enteral Syringe Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

10. Global Enteral Syringe Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Enteral Syringe Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Technology Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

11. Company Profiles
    • Abbott Laboratories Inc.
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Gerresheimer AG
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Terumo Corp.
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Becton
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Dickinson and Company
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Merit Medical Systems Inc.
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Technology Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • Medline Industries Inc.
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Technology Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Cardinal Health Inc.
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Technology Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • Schott AG
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Technology Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Braun Melsungen AG
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis
    • Retractable Technologies Inc.
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis
    • Smith’s Medical
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis
    • Terumo Medical Corporation
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
2. Global Catheter Tip Syringes, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
3. Global Single Use Enteral Syringes, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
4. Global Home Use Enteral Syringes, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
5. Global Others, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
6. Global Enteral Syringe Market, By Application, 2023–2030 (USD Million)
7. Global Neurological Disease, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
8. Global Oncology, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
9. Global GI Related Disease, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
10. Global Malnutrition, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
11. Global Others, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
12. Global Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
13. Global Adults, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
14. Global Neonatal & Pediatrics, Enteral Syringe Market, By Region, 2023–2030 (USD Million)
15. Global Enteral Syringe Market, By Region, 2023–2030 (USD Million)
16. North America Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
17. North America Enteral Syringe Market, By Application, 2023–2030 (USD Million)
18. North America Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
19. USA Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
20. USA Enteral Syringe Market, By Application, 2023–2030 (USD Million)
21. USA Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
22. Canada Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
23. Canada Enteral Syringe Market, By Application, 2023–2030 (USD Million)
24. Canada Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
25. Mexico Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
26. Mexico Enteral Syringe Market, By Application, 2023–2030 (USD Million)
27. Mexico Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
28. Europe Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
29. Europe Enteral Syringe Market, By Application, 2023–2030 (USD Million)
30. Europe Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
31. Germany Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
32. Germany Enteral Syringe Market, By Application, 2023–2030 (USD Million)
33. Germany Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
34. France Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
35. France Enteral Syringe Market, By Application, 2023–2030 (USD Million)
36. France Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
37. UK Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
38. UK Enteral Syringe Market, By Application, 2023–2030 (USD Million)
39. UK Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
40. Italy Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
41. Italy Enteral Syringe Market, By Application, 2023–2030 (USD Million)
42. Italy Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
43. Spain Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
44. Spain Enteral Syringe Market, By Application, 2023–2030 (USD Million)
45. Spain Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
46. Asia Pacific Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
47. Asia Pacific Enteral Syringe Market, By Application, 2023–2030 (USD Million)
48. Asia Pacific Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
49. Japan Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
50. Japan Enteral Syringe Market, By Application, 2023–2030 (USD Million)
51. Japan Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
52. China Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
53. China Enteral Syringe Market, By Application, 2023–2030 (USD Million)
54. China Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
55. India Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
56. India Enteral Syringe Market, By Application, 2023–2030 (USD Million)
57. India Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
58. South America Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
59. South America Enteral Syringe Market, By Application, 2023–2030 (USD Million)
60. South America Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
61. Brazil Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
62. Brazil Enteral Syringe Market, By Application, 2023–2030 (USD Million)
63. Brazil Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
64. Middle East and Africa Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
65. Middle East and Africa Enteral Syringe Market, By Application, 2023–2030 (USD Million)
66. Middle East and Africa Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
67. UAE Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
68. UAE Enteral Syringe Market, By Application, 2023–2030 (USD Million)
69. UAE Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)
70. South Africa Enteral Syringe Market, By Product Type, 2023–2030 (USD Million)
71. South Africa Enteral Syringe Market, By Application, 2023–2030 (USD Million)
72. South Africa Enteral Syringe Market, By Patient Group, 2023–2030 (USD Million)

List of Figures 

1. Global Enteral Syringe Market Segmentation
2. Enteral Syringe Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Enteral Syringe Market Attractiveness Analysis By Product Type
9. Global Enteral Syringe Market Attractiveness Analysis By Application
10. Global Enteral Syringe Market Attractiveness Analysis By Patient Group
11. Global Enteral Syringe Market Attractiveness Analysis By Region
12. Global Enteral Syringe Market: Dynamics
13. Global Enteral Syringe Market Share By Product Type (2023 & 2030)
14. Global Enteral Syringe Market Share By Application (2023 & 2030)
15. Global Enteral Syringe Market Share By Patient Group (2023 & 2030)
16. Global Enteral Syringe Market Share by Regions (2023 & 2030)
17. Global Enteral Syringe Market Share by Company (2021)